logo

Exhibiting at FOOD INGREDIENTS CHINA 2025

41J05
NECC (Shanghai)
17 Mar - 19 Mar, 2025

Media Gallery

Greenyn Biotechnology Company Overview

Product Offerings

Product Categories:

Nutrients, Functional Food, Dietary Supplements, Food Supplements / Nutraceuticals, Botanical Extracts, Enzymes, Antioxidants, Herbal products and remedies, Functional Food Ingredients

Products:

Health Ingredients: Antrodia cinnamomea mycelia, Bitter melon extract (Insumate®), Crassocephalum rabens extract (RabenLiv®, RabenWhite®), Citrus extract (Citrusvel®)

Health Formulations: 101 Phyto Fermented Drink (Zymologist)

Product Gallery:

Founded in 2003 and headquartered in Taichung City, Taiwan, GREENYN BIOTECHNOLOGY CO., LTD(綠茵生技股份有限公司)has emerged as a pioneering force in the biotechnology and nutraceutical industry. The company is dedicated to the development and commercialization of innovative, clinically supported botanical extracts and health supplements that emphasize both scientific rigor and traditional medicinal knowledge.

Core Business and Specialization

Greenyn Biotechnology operates as a vertically integrated entity, covering the full spectrum of research, development, production, and global distribution. The company's core competencies lie in the extraction and formulation of bioactive compounds from medicinal plants, particularly those native to Taiwan and East Asia. Greenyn is particularly known for its innovation in fermented health beverages and botanical extracts targeted toward metabolic health, liver function, immune regulation, and skincare.

Their proprietary biotechnology processes—especially in fermentation and extraction—set them apart in delivering high-efficacy products backed by peer-reviewed clinical data. The company holds numerous patents and trademarks, such as Insumate®, Antromax®, RabenLiv®, RabenWhite®, and Citrusvel®, representing its leading-edge solutions for blood sugar management, liver protection, and skin whitening.

Product Offerings

Greenyn's product portfolio is organized across two main segments:

  • Health Ingredients

    • Antrodia cinnamomea mycelia – A medicinal mushroom extract noted for hepatoprotective properties.
    • Bitter melon extract (Insumate®) – Clinically proven to support blood sugar control and insulin sensitivity.
    • Crassocephalum rabens extract (RabenLiv®, RabenWhite®) – Used for liver health and skin whitening applications.
    • Citrus extract (Citrusvel®) – Formulated for antioxidant benefits and immune modulation.
  • Health Formulations

    • 101 Phyto Fermented Drink (Zymologist) – A flagship fermented herbal beverage incorporating over 101 plant-based ingredients through advanced microbial fermentation techniques.

These products cater to functional food companies, dietary supplement brands, and pharmaceutical clients seeking ODM and OEM services with robust scientific support.

Financial and Business Strength

Greenyn Biotechnology maintains a strong financial position as a leading exporter and manufacturer in Taiwan's nutraceutical industry. While specific revenue data remains undisclosed, the company's participation in global expos such as Vitafoods Europe, CPhI Worldwide, and Health Ingredients Japan reflects its scale and influence. Its ingredients have passed multiple stages of international clinical validation, ensuring market entry in North America, Europe, and Southeast Asia.

Shipment and Export Records

According to publicly available trade data, Greenyn has consistently exported to the United States, Japan, and Europe, with multiple high-value shipments of herbal extracts and finished products. Records from platforms like ImportYeti and Volza show the company has made over 120 shipments globally in the last 3 years, signifying robust international demand.

Target Market and Customer Segments

Greenyn targets B2B customers in:

  • Nutraceutical and dietary supplement industries
  • Functional food and beverage manufacturers
  • Pharmaceutical and cosmeceutical sectors

Its key clients span North America, Southeast Asia, and Europe, particularly in markets with stringent quality standards—underscoring the company’s capabilities in compliance and innovation.

Capabilities and R&D Excellence

The company’s core capability lies in biotechnological innovation. Greenyn collaborates with academic institutions and medical centers across Taiwan and Asia for ongoing research and clinical studies. They possess:

  • Patented extraction techniques
  • GMP and HACCP-certified manufacturing facilities
  • In-house R&D labs equipped for phytochemical analysis, microbiology, and product formulation

Certifications and Compliance

Greenyn holds the following certifications, underscoring its compliance and commitment to global standards:

  • ISO 22000
  • HACCP
  • GMP (Good Manufacturing Practice)
  • Halal Certification
  • US FDA Dietary Supplement Health and Education Act (DSHEA) compliance

These certifications facilitate its seamless entry into highly regulated markets such as the United States, Japan, and the EU.

Customer Testimonials and Clinical Recognition

Greenyn’s flagship extract Insumate® has been the subject of multiple human clinical trials demonstrating statistically significant improvements in insulin sensitivity and HbA1c levels. Testimonials from global B2B clients highlight the brand’s scientific credibility and product consistency. One U.S.-based supplement manufacturer noted a 23% increase in customer retention after integrating Insumate® into its formulation portfolio.

Major Achievements

  • Awarded National Biotechnology Innovation Award by Taiwan’s Ministry of Economic Affairs
  • Featured in major international exhibitions: Vitafoods Europe, CPhI Worldwide, BIO Asia–Taiwan
  • Over 20 patents registered across Taiwan, China, and the United States
  • Clinically validated by institutions like China Medical University Hospital and Taipei Medical University

Greenyn Biotechnology continues to lead the functional ingredient market by merging traditional wisdom with modern biotechnology, delivering natural health solutions with clinical efficacy and commercial viability.